USPTO serial 87123982
MINE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHADAB, SETH WILLIG
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Princeton, NJ
Princeton, NJ
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
THOMAS M. PALISI
THOMAS M. PALISI LERNER, DAVID, LITTENBERG, KRUMHOLZ & MENTLIK, LLP600 SOUTH AVENUE WESTWESTFIELD, NJ 07090UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF IMMUNOLOGICAL CONDITIONS; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF TUMORS; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF IMMUNE SYSTEM CONDITIONS; MEDICINAL PREPARATIONS FOR THE TREATMENT OF INFECTIOUS DISEASES AND FOR USE IN ONCOLOGY; BIOPHARMACEUTICAL PREPARATIONS FOR PERSONALIZED CANCER IMMUNOTHERAPIES AND IMMUNO-ONCOLOGY THERAPIES | ACTIVE | — |
| 042 | PHARMACEUTICAL AND MEDICAL RESEARCH AND DEVELOPMENT IN THE FIELDS OF PHARMACEUTICAL AND BIOLOGICAL PREPARATIONS USED IN THE DIAGNOSIS AND TREATMENT OF CANCER AND PHARMACEUTICAL AND BIOLOGICAL PREPARATIONS USED IN ACTIVE SPECIFIC IMMUNOTHERAPY FOR THE TREATMENT OF CANCER; PROVIDING MEDICAL AND SCIENTIFIC RESEARCH INFORMATION IN THE FIELDS OF PHARMACEUTICALS, BIOLOGICALS, AND CLINICAL TRIALS; PROVIDING IMMUNOTHERAPY AND IMMUNO-ONCOLOGY PLATFORMS IN THE NATURE OF THE DEVELOPMENT OF BIOCHEMICAL ASSAYS FOR THE TREATMENT OF IMMUNE SYSTEM CONDITIONS AND CANCER | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 11, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 11, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 9, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 14, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 14, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 9, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 24, 2020 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 23, 2019 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 9, 2019 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 18, 2018 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 7, 2017 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 3, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jun 1, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 1, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 1, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 12, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 5, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 5, 2016 | NWAP | NEW APPLICATION ENTERED | — |